Co-led (with Molten Ventures) an oversubscribed extension bringing IMU Biosciences' Series A to over $53M for immune-system profiling.
JUN 2, 2026
Co-led IMU Biosciences' oversubscribed $53M Series A to decode the immune system at scale.
JUN 2, 2026
IMU Biosciences is pioneering HD Immunology to decode the immune system with unprecedented resolution and scale, transforming the understanding, diagnosis, and treatment of diseases
IMU Biosciences is pioneering HD Immunology to decode the immune system with unprecedented resolution and scale, transforming the understanding, diagnosis, and treatment of diseases.